UPDATE: Oppenheimer Starts Bio Blast Pharma (ORPN) at Outperform, Price Target $32

Go back to UPDATE: Oppenheimer Starts Bio Blast Pharma (ORPN) at Outperform, Price Target $32
Orient Paper, Inc. NEW (NASDAQ: ORPN) Delayed: 11.50 --0 (-0%)
Previous Close $11.50    52 Week High $7.95 
Open $10.61    52 Week Low $1.36 
Day High $11.50    P/E 21.30 
Day Low $11.50    EPS $0.54 
Volume 903,889